Delivery Order SPE2DB20D2104-SPE2DB25FMKMD
Award Date
3/6/25
Potential Completion Date
3/7/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order (SPE2DB24FN7V7) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,571,363 units of Atorvastatin 40 mg tablets. The contract has a ceiling value of $1,140.61 and a completion date of May 13, 2024. It is a Firm Fixed Price contract with no set-aside requirements. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,908.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 20 mg tablets in 1,000-count quantities, with a performance period through January 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,080.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4560830821 Atorvastatin 20 mg tablets. The contract is a delivery order with a firm fixed price and has a completion date of May 5, 2023. The award does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,294.35 firm fixed-price contract is for the delivery of 90-count atorvastatin 80 mg tablets. No set-aside was used for this award. Amerisourcebergen will provide this drug product to support the medical needs of military treatment facilities and other DLA customers through September 2024. This order is part of Amerisourcebergen's larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.82, is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, a medication used to treat cardiovascular conditions. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This order was not set aside for any specific business category. Amerisourcebergen...
This contract award, valued at $2,581.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,216,756 units of Atorvastatin 40 mg tablets, a cardiovascular medication, with a completion date of September 19, 2023. The award is a delivery order contract, with a firm fixed price pricing type. No set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,429.37 order is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, a generic pharmaceutical product. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has a history of providing pharmaceutical products and...
This federal contract award is for the delivery of Atorvastatin 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $12,468.26 with a firm fixed price, and the ultimate completion date is July 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,150.18 firm fixed-price delivery order contract is to provide AMLODIPINE-ATORVAST 10-20 MG 30S, a cardiovascular medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999...
The Defense Logistics Agency (DLA) awarded a $1,442.68 firm fixed price delivery order for AMLODIPINE-ATORVAST 10-20 MG 30S pharmaceutical products to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order has a completion date of February 14, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense. This delivery...